NESTLE WATERS NA
- Microbix Lawsuit in Germany Dismissed Without Prejudice Marketwire - Breaking News Releases
- Judge clears Novartis to market first U.S. biosimilar Pharmaceutical Care Management Association PCMA SmartBrief
- Novartis's cancer drug Jakavi gets approval in Europe to treat polycythemia vera Pharmaceutical Business Review
- Post closing PowerBar plant IFT.org
- BRIEF-Oxford Biomedica FY revenue excluding grants 13.6 mln stg vs 5.4 mln stg Reuters - Sectors - Healthcare
- Novartis cancer drug gets FDA's first 'biosimilar' nod Modern Healthcare Business News
- Arrowhead buys Novartis' RNAi portfolio Reuters - Sectors - Healthcare
- Arrowhead Acquires Novartis' RNAi Assets Contract Pharma - Breaking News
- Array BioPharma completes $85M acquisition of Novartis' oncology drug candidates Biotechnology Industry Organization BIO SmartBrief
- GSK deal's done. Now, Novartis has to deliver on cancer-growth pledge Fierce Pharma
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on NESTLE WATERS NA
- Rate NESTLE WATERS NA on their payment behavior
- Ask your network about NESTLE WATERS NA with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.